GlassScriptPhysician profile
Shawn Sell
NPI 1124517966
$1,349.06
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $79.93 · 2021: $171 · 2022: $222 · 2023: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $185.53 | 2022-2023 | Omni Surgical System |
| Allergan, INC. | $149.99 | 2019-2020 | |
| Dompe US, INC. | $129.16 | 2021 | |
| Mallinckrodt Enterprises LLC | $118.75 | 2019 | |
| Pfizer INC. | $115.38 | 2019 | |
| Mallinckrodt Hospital Products INC. | $111.84 | 2021-2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $99.27 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $81.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $71.28 | 2023 | Cequa |
| Alexion Pharmaceuticals, INC. | $69.45 | 2022 | |
| Oyster Point Pharma, INC. | $62.32 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $53.40 | 2019-2020 | |
| Horizon Therapeutics Plc | $26.25 | 2021 | |
| Omeros Corporation | $23.16 | 2019 | |
| Rayner Intraocular Lenses Limited | $19.43 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $16.56 | 2023 | Envista Mx60 Iol |
| Eyevance Pharmaceuticals LLC | $16.29 | 2023 | Flarex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Sell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.